🌿 SkincareDB

HYDROQUINONE

INCI Name HYDROQUINONE
CAS Number 123-31-9
πŸ‡ͺπŸ‡Ί Banned
πŸ‡ΊπŸ‡Έ Approved
πŸ‡―πŸ‡΅ Approved
πŸ‡°πŸ‡· Banned
πŸ‡¬πŸ‡§ Restricted

Overview

HYDROQUINONE is a phenolic compound used in cosmetics primarily as a skin-brightening agent that inhibits tyrosinase, the key enzyme in melanin synthesis. It has been used clinically for decades to treat hyperpigmentation conditions including melasma and post-inflammatory hyperpigmentation, and is classified as a pharmaceutical drug in several markets due to its potency and potential side effects. In the EU, it has been banned from cosmetic formulations since 2001; in the US, the FDA removed its over-the-counter GRASE (Generally Recognized As Safe and Effective) status in 2020, making it available by prescription only; in Japan, it is permitted in quasi-drugs at defined concentrations. Users should be aware that prolonged use at high concentrations may carry risks including ochronosis, and use should be limited and supervised.

Also known as: Quinol, 1,4-Dihydroxybenzene, p-Dihydroxybenzene, p-Hydroquinone

Key Benefits

Clinical evidence indicates that hydroquinone is among the most studied depigmenting agents, and studies suggest it may produce measurable reductions in melanin content in areas of hyperpigmentation such as melasma and age spots. However, due to the regulatory status and potential for adverse effects, its use is subject to significant market restrictions.

Supporting Research

  • β€’ Torok et al. (2005) – 4% hydroquinone with tretinoin and fluocinolone acetonide for melasma (Cutis)
  • β€’ Draelos (2007) – review of skin lightening and hydroquinone safety considerations (Dermatol Ther)

Skin Compatibility Ratings

Comedogenic Rating

0/5

No comedogenic potential documented

Source: Cosmetic dermatology literature

Irritancy Rating

3/5

High irritancy potential at concentrations used for depigmentation; may cause erythema, burning, and contact dermatitis. Risk of exogenous ochronosis (paradoxical darkening) with prolonged use, particularly on darker skin types.

Source: FDA review dossier; clinical literature

Typical Use Concentration

Range

2–4%

Optimal

2% (where OTC permitted); 4% (Rx)

OTC use at 2% previously permitted in the US until FDA removed GRASE status in 2020. 4% available by prescription in the US. Japan quasi-drug allows low concentrations. EU banned in cosmetics (Annex II) since 2001.

Works Well With / Avoid

Works Well With

tretinoin corticosteroids

Avoid Combining

resorcinol hydrogen-peroxide

Use With Caution

strong acids oxidizing agents

Historically used in combination with tretinoin and a mild corticosteroid (Kligman formula). Oxidizes on exposure to light and air; formulations require antioxidants and light-protective packaging.

Commonly Found In

Prescription Skin Lighteners Dermatological Treatments

Global Regulation Summary

Overview of current status across major international markets.

🚫 2 Banned
⚠️ 1 Restricted
βœ… 2 Allowed/Other

Detailed Regional Status

Region Status Max Conc. Conditions Source
πŸ‡ͺπŸ‡Ί EU Banned - - Official β†—
πŸ‡ΊπŸ‡Έ USA Allowed - - Official β†—
πŸ‡―πŸ‡΅ Japan Allowed - - Official β†—
πŸ‡°πŸ‡· Korea Banned - Prohibited in general cosmetics (up to 0.02% allowed in artificial nail systems) Official β†—
πŸ‡¬πŸ‡§ UK Restricted - Follows EU regulations (II/1339 III/14) Official β†—

🌍 Why Regulations Differ

Hydroquinone shows one of the most divergent regulatory profiles of any skin-active ingredient. The EU banned it in cosmetics in 2001 due to concerns about carcinogenicity and ochronosis risk. The US FDA removed its OTC status in 2020, reclassifying it as a drug requiring prescription. Japan permits it in quasi-drugs at regulated concentrations. South Korea bans it in general cosmetics. These differences reflect different risk-benefit assessments and national classification frameworks.

Recent Regulatory Changes

  • β€’ US FDA: removed OTC GRASE status for 2% hydroquinone skin bleaching products in 2020; available by Rx only
  • β€’ EU: banned under Annex II since 2001 (Directive 2000/6/EC)

Regulation Analysis

Regional Agreement

High regulatory divergence

Banned in EU, Korea but allowed in USA, Japan.

Category Comparison

There are 34 ingredients in the LIGHT STABILIZER category. 100% are banned in at least one major market.

Strictness Ranking

1.EUBanned
2.KoreaBanned
3.UKRestricted
4.USAAllowed
5.JapanAllowed

🌿 Natural Sources

Found in small amounts in coffee, tea, wheat, and berries. Also present in some fungal species.

🏭 How It's Made

Synthesized through hydroxylation of phenol or reduction of benzoquinone. Historically extracted from photographic developer chemicals.

πŸ’„ Uses in Cosmetics

Used at 2% (over-the-counter) to 4% (prescription) for treating dark spots, age spots, and uneven skin tone. Banned in EU cosmetics due to safety concerns, but allowed with restrictions in the US and Japan.

LIGHT STABILIZER

πŸ”¬ Other Applications

Used in photographic development, as a reducing agent in chemistry, and in some pharmaceutical preparations.

πŸ’‘ Fun Facts

  • β€’ Hydroquinone was used in photographic development since the 1800s before its cosmetic applications were discovered
  • β€’ The EU banned it in cosmetics in 2001, but the same compound remains allowed in the US at 2% for OTC products
  • β€’ Named from 'hydro-' (hydrogen) and 'quinone', reflecting its chemical structure as a reduced form of benzoquinone

Related Skin Concerns

Data Sources

  • β€’ EU Cosmetics Regulation Annex II (banned substances)
  • β€’ FDA Final Rule on OTC skin bleaching products 2020
  • β€’ Japan MHLW quasi-drug regulations
  • β€’ CIR Expert Panel review on hydroquinone
  • β€’ Draelos, Dermatol Ther 2007;20(5):308-313

Last data verification: 2026-04-12

Related Ingredients

Learn More

Frequently Asked Questions

Why is HYDROQUINONE banned in the EU but allowed in the US?

The EU follows a precautionary principle, banning HYDROQUINONE under II/1339 III/14 due to potential safety concerns. The US FDA has not found sufficient evidence to prohibit its use, allowing it under different safety assessment standards. This reflects differing regulatory philosophies between the two regions.

Why is HYDROQUINONE banned in the EU but allowed in Japan?

The EU prohibits HYDROQUINONE (II/1339 III/14) based on their strict safety criteria. Japan's Ministry of Health, Labour and Welfare (MHLW) has evaluated the ingredient and permits its use, potentially with different safety data or usage conditions.

What is HYDROQUINONE used for in cosmetics?

HYDROQUINONE is primarily used for light stabilizer in cosmetic products. The ingredient is commonly found in various cosmetic and personal care products.

Which countries regulate HYDROQUINONE?

HYDROQUINONE is banned in EU, KR. It has concentration limits or usage restrictions in UK. The ingredient is freely allowed in JP, US.

Are there alternatives to HYDROQUINONE?

Due to regulatory restrictions on HYDROQUINONE, cosmetic manufacturers often use alternative ingredients with similar functions. For light stabilizer, alternatives may include other approved ingredients in the same category. Consult product labels for specific formulations, and look for products compliant with your region's regulations.

⚠️

Disclaimer

The information on this website is for educational and informational purposes only and is not intended as medical advice. While we strive for accuracy based on official government databases, cosmetic regulations change frequently. Always consult with a qualified professional or refer to the latest official regulatory documents for compliance. We are not responsible for any actions taken based on the information provided here.